See more : Axiomtek Co., Ltd. (3088.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of The Valens Company Inc. (VLNS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Valens Company Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- TSR, Inc. (TSRI) Income Statement Analysis – Financial Results
- G2 Energy Corp. (GTGEF) Income Statement Analysis – Financial Results
- Lexibook – Linguistic Electronic System Société anonyme (ALLEX.PA) Income Statement Analysis – Financial Results
- Mangalam Organics Limited (MANORG.NS) Income Statement Analysis – Financial Results
- Bosideng International Holdings Limited (3998.HK) Income Statement Analysis – Financial Results
The Valens Company Inc. (VLNS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thevalenscompany.com
About The Valens Company Inc.
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles, natural health, and other products. In addition, it offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, product development, and custom manufacturing services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.
The Valens Company announces white label partnership with leading, technology-powered, cannabis retailer Fire & Flower
The Valens Company to Acquire Leading, Premium Craft Licensed Producer, Citizen Stash Cannabis Corp.
The Valens Company in expansion mode with entry into New Brunswick cannabis market
Valens inks deal with Rubicon Organics to develop customized Cannabis 2.0 products
The Valens Company lays out operational priorities at its two Cannabis 2.0 manufacturing facilities; updates on LYF acquisition
Valens Set To Be More Aggressive In 2021 (Podcast Transcript)
Valens Set To Be More Aggressive In 2021 (Podcast)
Source: https://incomestatements.info
Category: Stock Reports